Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin H Cohen

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
American Journal of Hematology|March 5, 2010
FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney diseaseMin Lu, Martin H Cohen, Dwaine Rieves, et al.
The Oncologist|July 1, 2008
FDA drug approval summary: nelarabine (Arranon) for the treatment of T-cell lymphoblastic leukemia/lymphomaMartin H Cohen, John R Johnson, Robert Justice, et al.
The Oncologist|May 31, 2012
Approval summary: imatinib mesylate for one or three years in the adjuvant treatment of gastrointestinal stromal tumorsMartin H Cohen, John R Johnson, Robert Justice, et al.
The Oncologist|November 18, 2011
Approval summary: letrozole (Femara® tablets) for adjuvant and extended adjuvant postmenopausal breast cancer treatment: conversion of accelerated to full approvalMartin H Cohen, John R Johnson, Robert Justice, et al.
The Oncologist|November 10, 2009
FDA drug approval summary: bevacizumab (Avastin) as treatment of recurrent glioblastoma multiformeMartin H Cohen, Yuan Li Shen, Patricia Keegan, et al.
The Oncologist|March 14, 2009
FDA review of a panitumumab (Vectibix) clinical trial for first-line treatment of metastatic colorectal cancerRuthann M Giusti, Martin H Cohen, Patricia Keegan, et al.
The Oncologist|December 20, 2002
FDA drug approval summaries: fulvestrantPeter F Bross, Martin H Cohen, Grant A Williams, et al.
The Oncologist|September 4, 2007
FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL)Patricia Anne Dinndorf, Joseph Gootenberg, Martin H Cohen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
Approval summary: letrozole in the treatment of postmenopausal women with advanced breast cancerMartin H Cohen, John R Johnson, Ning Li, et al.
The Oncologist|August 5, 2003
FDA drug approval summary: gefitinib (ZD1839) (Iressa) tabletsMartin H Cohen, Grant A Williams, Rajeshwari Sridhara, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
American Journal of Hematology|March 5, 2010
FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney diseaseMin Lu, Martin H Cohen, Dwaine Rieves, et al.
The Oncologist|July 1, 2008
FDA drug approval summary: nelarabine (Arranon) for the treatment of T-cell lymphoblastic leukemia/lymphomaMartin H Cohen, John R Johnson, Robert Justice, et al.
The Oncologist|May 31, 2012
Approval summary: imatinib mesylate for one or three years in the adjuvant treatment of gastrointestinal stromal tumorsMartin H Cohen, John R Johnson, Robert Justice, et al.
The Oncologist|November 18, 2011
Approval summary: letrozole (Femara® tablets) for adjuvant and extended adjuvant postmenopausal breast cancer treatment: conversion of accelerated to full approvalMartin H Cohen, John R Johnson, Robert Justice, et al.
The Oncologist|November 10, 2009
FDA drug approval summary: bevacizumab (Avastin) as treatment of recurrent glioblastoma multiformeMartin H Cohen, Yuan Li Shen, Patricia Keegan, et al.
The Oncologist|March 14, 2009
FDA review of a panitumumab (Vectibix) clinical trial for first-line treatment of metastatic colorectal cancerRuthann M Giusti, Martin H Cohen, Patricia Keegan, et al.
The Oncologist|December 20, 2002
FDA drug approval summaries: fulvestrantPeter F Bross, Martin H Cohen, Grant A Williams, et al.
The Oncologist|September 4, 2007
FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL)Patricia Anne Dinndorf, Joseph Gootenberg, Martin H Cohen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
Approval summary: letrozole in the treatment of postmenopausal women with advanced breast cancerMartin H Cohen, John R Johnson, Ning Li, et al.
The Oncologist|August 5, 2003
FDA drug approval summary: gefitinib (ZD1839) (Iressa) tabletsMartin H Cohen, Grant A Williams, Rajeshwari Sridhara, et al.
Pageof 4